Latest filing published 12 Aug 2025 for Treace Medical Concepts, INC..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Aaron Berutti: trading record in brief
All filings by Aaron Berutti on record concern Treace Medical Concepts, Inc., in the capacity of senior executive. We count 13 filings; the first trade dates from 8 March 2022 and the latest from 9 August 2025.
Both buying and selling appear: 1 purchase worth €39k, against 1 sale worth €17k. Netting one side against the other leaves €22k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 11 share grants.
The record was last updated on 12 August 2025 with a share grant in Treace Medical Concepts, Inc. The last insider purchase was made public on 21 November 2022, 1,449 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Aaron Berutti
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,907 shares0Common StockSEC:0000950170-25-107554:0
- 728 shares0Common StockSEC:0000950170-25-037575:0
- 75,000 shares0Common StockSEC:0000950170-25-008974:0
- 4,821 shares0Common StockSEC:0000950170-25-005578:0
- 60,450 shares0Common StockSEC:0000950170-24-095010:0
- 711 shares0Common StockSEC:0000950170-24-030473:0
- 65,025 shares0Common StockSEC:0001209191-24-001593:0
- 733 shares@ US$24.4130.5% of flowCommon StockSEC:0001209191-23-018044:0
- 1,825 shares@ US$21.859969.5% of flowCommon StockSEC:0001209191-22-058268:0Canonical exit: 19 Feb 2023 (T+90)
- 11,950 shares0Common StockSEC:0001567619-22-006726:0
10 of 10 declarations
